National coordination and clearer rules for smoother introduction of digital tools into Swedish healthcare
News • Nov 08, 2018 09:23 GMT
Small and medium-sized enterprises (SMEs) have great difficulties in finding out what is required to get their digital products into public healthcare. Patients seeking help and support have limited insight into what digital tools are available. At the same time, public healthcare is struggling to find new ways to digitalize parts of their offering. This calls for common rules and national coordination to secure a smooth introduction of digital tools into healthcare.
To contribute to necessary change that will lead to cutting edge digitalization of Swedish healthcare, as well as getting the most out of Swedish inventions and new products, we at Uppsala BIO have been an active part in driving this agenda forward.
We were part of initiating a pilot study in 2016, which in 2017 led to the start of Ordnat införande av digitala produkter och tjänster (ordered introduction of digital products and services). This is a collaborative effort led by SKL (Sveriges Kommuner och Landsting/Swedish Association of Local Authorities and Regions) together with Region Norrbotten, Stockholm Science City and Uppsala BIO. Uppsala BIO is represented in the project team by Erik Olaisson, and by Erik Forsberg in the project steering group.
The aim of the project is to facilitate the implementation and introduction of digital tools into healthcare, thereby contributing to increased growth in SMEs as well as supporting the Vision e-Health 2025.
The first delivery from the project is the report Tydligare spelregler och samordning av krav – Rekommendationer till nytta för patient, vård och företag (clearer rules and coordination of claims with recommendations to the benefit of patients, healthcare and business). It describes the challenges that county councils, regions and businesses are faced with in the process of providing digital tools for patients with prescribed self-care.
The project presents eight proposals on how to better utilize the potential of digital products and services:
- Develop and implement a joint national framework
- Establish coordination and synergies for medical devices and IT
- Adopt the proposal for a national infrastructure to support information management for digital services for prescribed self-care
- Create a library of claims (to clarify and coordinate requirements)
- National coordination of priorities and recommendations for digital services
- Investigate joint procurement on a national level
- Increased ability for digital transformation
- Product summary developed by the industry
The project will continue into 2019 to further develop and anchor some of the proposals presented in the report. We have also proposed that this effort should become an initiative within Vision e-Health 2025, thereby being officially supported ty the Swedish government and SKL (Sveriges Kommuner och Landsting/Swedish Association of Local Authorities and Regions).
Find the reports and more info through the links below:
Tydligare spelregler och samordning av krav (the report)
Hälsa Hem – för tillgänglig och jämlik vård (the pilot study report)
Vision e-Hälsa 2025 (in Swedish)
Vision e-Health 2025 (in English)
Uppsala BIO was part of initiating a pilot study in 2016, which in 2017 led to Ordnat införande av digitala produkter och tjänster (ordered introduction of digital products and services), a collaborative effort led by SKL (Sveriges Kommuner och Landsting/ Swedish Association of Local Authorities and Regions) together with Region Norrbotten, Stockholm Science City and Uppsala BIO.
News • Aug 23, 2018 11:26 GMT
On 21 August, Testa Center – Sweden’s national test environment for verifying biological and technological tools used in manufacturing biologics or biopharmaceuticals – was officially inaugurated. And the first projects are ready to move in and get going!
News • Aug 23, 2018 11:14 GMT
This August, we see a new and exciting addition to Uppsala`s life science business sector. Based on research by Professor Gert Auer at Karolinska Institute, NeoProteomics AB started the development of biomarkers for sensitive and risk-free cancer diagnosis by analyzing platelets role in cancer. Blood-based liquid biopsy products for cancer diagnosis are extremely patient friendly and safecompared to current tissue biopsies, and a growing market. Company focus is now to develop the first in a series of products based on proprietary platelet biomarkers. The first diagnostic product for early detection of colorectal cancer will be ready for testing next year.
Uppsala offers a great environment for life science-based companies. We believe that Uppsala is a good location when you plan to develop a new life science company with growth potential and we are pleased to start our activities based in Uppsala Business Park this autumn says Torbjörn Pettersson, CEO of the company.
This August, we see a new and exciting addition to Uppsala`s life science business sector. Based on research by Professor Gert Auer at Karolinska Institute, NeoProteomics AB started the development of biomarkers for sensitive and risk-free cancer diagnosis by analyzing platelets role in cancer.
News • Aug 21, 2018 14:12 GMT
Uppsala-based life science company Cavidi is an expert in HIV monitoring. Its first commercial product was a manual test for HIV monitoring in resource-limited settings, ExaVir Load. This product was an important step in taking care closer to the HIV-infected population in the parts of the world that are most affected.
News • Jun 14, 2018 12:48 GMT
Companies developing digital products also face a challenge: the demands made on their products and services are not always entirely clear. The question, therefore, is how can we simplify and improve the introduction of digital solutions?
News • May 24, 2018 08:56 GMT
Conextion, operational since its inauguration in January 2018, involves and gathers together a large number of life sciences employees, business consultants and representatives from the public support system. To see how we best can serve these interested parties, a number of activities have been tested.
Strong growth for Uppsala’s life science companies. Powerful force of attraction for other businesses.
News • Apr 26, 2018 11:12 GMT
It is very pleasing to note that Uppsala’s industrial development continues unabated. Our region is home to many prosperous and profitable businesses. Together with the universities, hospitals and national authorities in the region, they exert a powerful force of attraction that can draw other companies to Uppsala, writes Erik Forsberg, Managing Director at Uppsala BIO.
News • Apr 26, 2018 10:54 GMT
We at Uppsala BIO congratulate Kontigo Care, this week recognised with the eHealth Award 2018! The Uppsala-based company has developed Previct, a digital e-health platform that uses advanced AI (Artificial Intelligence) to enable patient diagnosis, care and aftercare.
News • Apr 26, 2018 08:20 GMT
That UIC is a key player in the business incubator world is well known. Now it has received Vinnova funding to carry out a pilot project aimed at developing a Swedish national platform for cutting-edge expertise in early-stage life science companies. Magnus Engevik, who works with business development at Uppsala BIO, has talked about the initiative with representatives of Vinnova and UIC.
News • Apr 26, 2018 07:12 GMT
How can novel technologies be used to create new and more effective treatments, promote health, improve patient experiences and reduce healthcare costs? During 2017 to 2019, Uppsala BIO is participating in a working group looking closely at the opportunities and challenges of introducing new digital technologies in healthcare.
About Uppsala BIO
Uppsala BIO brings together companies, universities, healthcare and society to fuel innovation and stimulate growth in the life science sector. Together we advance the sector's international competitiveness. Uppsala BIO is a part of the non-for-profit foundation STUNS.
- Uppsala BIO
- Uppsala Science Park
- SE-75183 Uppsala